In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi

Parasitology Research

Volumn 100, Issue 4, 2007, Pages 791-795

  Saraiva, Juliana ^a   Vega, Celeste ^b   Rolon, Mirian ^b   Da Silva, Rosangela ^c   E Silva, Márcio Luis Andrade ^c   Donate, Paulo Marcos ^a   Bastos, Jairo Kenupp ^a   Gomez Barrio, Alícia ^b   De Albuquerque, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSIDADE DE FRANCA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

6,6' DINITROHINOKININ; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CUBEBIN; DIMETHOXYMORELENSIN; HINOKININ; LACTONE DERIVATIVE; LIGNAN DERIVATIVE; NIFURTIMOX; O BENZYLCUBEBIN; O METHYLCUBEBIN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; EPIMASTIGOTE; IC 50; MALE; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTONES; LIGNANS; MICE; MOLECULAR STRUCTURE; TIME FACTORS; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 33846578254     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-006-0327-4     Document Type: Article

References (24)

1. Bastos JK, Gottlieb OR, Sarti SJ, Santos Filho D (1996) The isolation of lignans and sesquiterpenoids from leaves of Zanthoxylum naranjillo. Nat Prod Lett 9:65-70
2. Bastos JK, Albuquerque S, Silva ML (1999) Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med 65(6):541-544
3. Bode JW, Doyle MP, Protopopova MN, Zhou QL (1996) Intramolecular regioselective insertion into unactivated prochiral carbon-hydrogen bonds with diazoacetates catalyzed by chiral dirhodium(II) carboxamidates. Highly enantioselective total synthesis of natural lignan lactones. J Org Chem 61:9146-9155
4. Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing betagalactosidase. Antimicrob Agents Chemother 40:2592-2597
5. Brener Z (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4:389-396
6. Castellani O, Ribeiro LV, Fernandes JF (1967) Differentiation of Trypanosoma cruzi in culture. J Protozool 14(3):447-451
7. Croft SL (1997) The current status of antiparasite chemotherapy. Parasitology 114(Suppl):3-15
8. da Silva R, de Souza GH, da Silva AA, de Souza VA, Pereira AC, Royo Vde A, E Silva ML, Donate PM, de Matos Araujo AL, Carvalho JC, Bastos JK (2005) Synthesis and biological activity evaluation of lignan lactones derived from (-)-cubebin. Bioorg Med Chem Lett 15(4):1033-1037
9. de Castro SL (1993) The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 53(2):83-98
10. de Souza VA, da Silva R, Pereira AC, Royo Vde A, Saraiva J, Montanheiro M, de Souza GH, da Silva Filho AA, Grando MD, Donate PM, Bastos JK, Albuquerque S, e Silva ML (2005) Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett 2005 15(2):303-307
11. Docampo R (2001) Recent developments in the chemotherapy of Chagas disease. Curr Pharm Des 7(12):1157-1164
12. Filardi LS, Brener Z (1987) Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81(5):755-759
13. Heleno VCG, da Silva R, Pedersoli S, Albuquerque S, Bastos JK, e Silva MLA, Donate PM, da Silva GVJ, Lopes JLC (2006) Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones. Spectrochim Acta Part A 63:234-239
14. Martinez-Diaz RA, Escario JA, Nogal-Ruiz JJ, Gomez-Barrio A (2001) Biological characterization of Trypanosoma cruzi strains. Mem Inst Oswaldo Cruz 96(1):53-59
15. Muelas-Serrano S, Le-Senne A, Fernandez-Portillo C, Nogal JJ, Ochoa C, Gomez-Barrio A (2002) In vitro and in vivo anti-Trypanosoma cruzi activity of a novel nitro-derivative. Mem Inst Oswaldo Cruz 97(4):553-557
16. Murta SM, Gazzinelli RT, Brener Z, Romanha AJ (1998) Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol 93(2):203-214
17. Ochoa C, Perez E, Perez R, Suarez M, Ochoa E, Rodriguez H, Gomez Barrio A, Muelas S, Nogal JJ, Martinez RA (1999) Synthesis and antiprotozoan properties of new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives. Arzneim-Forsch 49(9):764-769
18. Paulino M, Iribarne F, Dubin M, Aguilera-Morales S, Tapia O, Stoppani AO (2005) The chemotherapy of Chagas' disease: an overview. Mini Rev Med Chem 5(5):499-519
19. Rodriques Coura J, de Castro SL (2002) A critical review on Chagas' disease chemotherapy. Mem Inst Oswaldo Cruz 97(1):3-24
20. Rolon M, Seco EM, Vega C, Nogal JJ, Escario JA, Gomez-Barrio A, Malpartida F (2006) Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosomacruzi. Int J Antimicrob Agents 28(2):104-109
21. Souza GH, da Silva Filho AA, de Souza VA, Pereira AC, Royo Vde A, e Silva ML, da Silva R, Donate PM, Carvalho JC, Bastos JK (2004) Analgesic and anti-inflammatory activities evaluation of (-)-O-acetyl, (-)-O-methyl, (-)-O-dimethylethylamine cubebin and their preparation from (-)-cubebin. Farmaco 59(1):55-61
22. Urbina JA, Docampo R (2003) Specific chemotherapy of Chagas' disease: controversies and advances. Trends Parasitol 19(11):495-501
23. Vega C, Rolon M, Martinez-Fernandez AR, Escario JA, Gomez-Barrio A (2005) A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing β-galactosidase. Parasitol Res 95(4):296-298
24. WHO (2003) http://www.who.int/tdr/dw/chagas2003.htm